Brief: BriaCell Therapeutics Corp Has Approved Measures To Address "Alleged Illegal Trading" Activity Of Its Publicly Traded Securities
23/01/2023 13:43
Jan 23 (Reuters) - Briacell Therapeutics Corp BCT.TO :
* BRIACELL THERAPEUTICS CORP: HAS APPROVED MEASURES TO
ADDRESS
"ALLEGED ILLEGAL TRADING" ACTIVITY OF ITS PUBLICLY TRADED
SECURITIES
* BRIACELL THERAPEUTICS CORP - IMPLEMENTING A PLAN TO
ADDRESS
ISSUE OF ILLEGAL TRADING ACTIVITY WHICH MAY INCLUDE LEGAL ACTION
Source text for Eikon: ID:nGNX1NZp7q
Further company coverage: BCT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study